AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge
(Reuters) – A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market…